NCT03338725 (EACPharModel) is a NA clinical trial of Clinical pharmacy model in Pharmaceutical Services, sponsored by Universidad de Antioquia.

Who is sponsoring NCT03338725?

NCT03338725 is sponsored by Universidad de Antioquia.

What drugs are being tested in NCT03338725?

Interventions in NCT03338725: Clinical pharmacy model.

What condition does NCT03338725 study?

NCT03338725 studies Pharmaceutical Services, Medication Errors, Drug-Related Side Effects and Adverse Reactions, Outcome Assessment (Health Care).

Is NCT03338725 still recruiting?

NCT03338725 is currently completed. Last updated 12 November 2020.

Last reviewed 2020-11-12 · How we verify

NCT03338725: EACPharModel

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effect and Associated Factors of the Clinical Pharmacy Model in the Incidence of Medical Errors

Completed NA Last updated 12 November 2020

What this trial tests

NA trial testing Clinical pharmacy model in Pharmaceutical Services in 720 participants. Completed in 10 November 2020.

Timeline

1 February 2018

Primary endpoint
30 May 2019

10 November 2020

Quick facts

Lead sponsor	Universidad de Antioquia
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	sequential
Masking	single
Primary purpose	health services research
Enrollment	720
Start date	1 February 2018
Primary completion	30 May 2019
Estimated completion	10 November 2020
Sites	1 location across Colombia

Drugs / interventions tested

Clinical pharmacy model

Conditions studied

Pharmaceutical Services — all drugs for Pharmaceutical Services →
Medication Errors — all drugs for Medication Errors →
Drug-Related Side Effects and Adverse Reactions — all drugs for Drug-Related Side Effects and Adverse Reactions →
Outcome Assessment (Health Care) — all drugs for Outcome Assessment (Health Care) →

Sponsor

Universidad de Antioquia — full company profile →

Who can join

Eligibility, any sex, with Pharmaceutical Services or Medication Errors. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Medication errors are considered by WHO to be a subject that requires attention at all levels of care, in order to reduce the serious and preventable damage related to medication. These strategies are aimed at the patient's safety policy. In Colombia, at the regulatory level there is no standardized clinical pharmacy model where the role of the clinical pharmacist is described extensively and in detail, and in addition, data are unknown of the scope or direct effect of the incorporation of this model in the assistance in the results of health care. The Hospital Pablo Tobón Uribe, it is a highly complex institution in Medellin (Colombia), certified by Join Comission International (JCI), which requires the continuous interaction of the pharmacist in patient care, in order to avoid medication errors and contribute to patient safety indicators. In this sense, the hospital structured and implemented a clinical pharmacy model that establishes the activities of the pharmacist incorporated into the care team in the patient attention. Today this model is applied in the institution, however, it is necessary to know the effect of its application in the solution of drug-related problems (DRPs) or a negative outcome related to medicine. The objective of this study is to know the effect on patient safety of a clinical pharmacy model in a hospital of high complexity and framed in the WHO initiative to reduce these errors of medication.

Publications & conference data

4 peer-reviewed publications reference this trial (live from Europe PMC):

Reducing medication errors for adults in hospital settings.
Ciapponi A, Fernandez Nievas SE, Seijo M, Rodríguez MB, et al · · 2021 · cited 41× · PMID 34822165 · DOI 10.1002/14651858.cd009985.pub2
Effect and associated factors of a clinical pharmacy model in the incidence of medication errors (EACPharModel) in the Hospital Pablo Tobón Uribe: study protocol for a stepped wedge randomized controlled trial (NCT03338725).
Granados J, Salazar-Ospina A, Botero-Aguirre JP, Valencia-Quintero AF, et al · · 2020 · cited 5× · PMID 31907009 · DOI 10.1186/s13063-019-3945-8
Effect and associated factors of a clinical pharmacy model in the incidence of medication errors in the hospital Pablo Tobón Uribe eacpharmodel study: stepped wedge randomized controlled Trial (NCT03338725).
Granados J, Amariles P, Botero-Aguirre JP, Ortiz-Cano NA, et al · · 2022 · cited 1× · PMID 34977994 · DOI 10.1007/s11096-021-01361-9
Effect and Associated Factors of a Clinical Pharmacy Model in the Incidence of Medication Errors in the Hospital Pablo Tobón Uribe Eacpharmodel Study: Stepped Wedge Randomized Controlled Trial (NCT03338725).
Granados J, Amariles P, Botero-Aguirre JP, Ortiz-Cano NA, et al · · 2021 · DOI 10.21203/rs.3.rs-268016/v1

Verify or expand the search:

Other recruiting trials for Pharmaceutical Services

Currently open trials in the same condition.

NCT06823037 — Hormonal Contraception Access Through Pharmacist Prescribing Implementation · NA · recruiting

Other Universidad de Antioquia trials

Trials by the same sponsor.

NCT06774274 — Analgesic Efficacy of Intravenous Ketamine as a Continuous Infusion vs PCA in the Management of Acute Postoperative Pain · Phase 4 · recruiting
NCT06693869 — The Risk of Surgical Cancellation in Adult Patients Assessed by Telephone Versus In-person for Scheduled Non-cardiac Ele · not yet recruiting
NCT07179432 — Effectiveness of Facial Mask NIV in Adults Under General Anesthesia: Two-Hand C-E vs V-E Techniques · NA · recruiting
NCT06742827 — Educational Intervention and Adherence · NA · active not recruiting
NCT06911736 — Effect of the Postoperative Trendelenburg Position on Chronic Subdural Hematoma Recurrence · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03338725 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Universidad de Antioquia
Last refreshed: 12 November 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03338725.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing